US FDA Implementing Hybrid Work Policy In January
Agency employees will have on-site, telework and remote possibilities, but options will depend on the center, office and job duties.
You may also be interested in...
The CBER director has worried that ‘someone’ might try to end the US FDA’s hybrid work policy. Now the push against it is bipartisan.
Combination of an aging workforce and departures that were delayed by the pandemic are taking a toll on the agency’s current staffing levels, Chief of Staff Julie Tierney says.
CBER Director Peter Marks said the FDA’s remote and in-person work system is functioning well and continues to help recruitment.